Literature DB >> 19335026

Severe infantile carnitine palmitoyltransferase II deficiency in 19-week fetal sibs.

Karen Meir1, Yakov Fellig, Vardiella Meiner, Stanley H Korman, Avraham Shaag, Michel Nadjari, Dov Soffer, Ilana Ariel.   

Abstract

Antenatal presentation of carnitine palmitoyltransferase type II deficiency due to mutations in the CPT2 gene has been rarely reported. We report an Ashkenazi Jewish family with 3 terminated pregnancies for multicystic kidneys and/or hydrocephalus. Fetal autopsy after termination of the couple's 4th pregnancy (sib 2) showed renal parenchyma replaced by cysts that appeared to increase in diameter toward the medulla. Fetopsy after termination of the 7th pregnancy (sib 3) revealed micrognathia; hypospadias; cystic renal dysplasia; hepatosteatosis; and lipid accumulation in the renal tubular epithelium, myocardium, and skeletal muscle. Microvascular proliferative changes and focal polymicrogyria were seen in the brain. A beta-oxidative enzyme deficiency was suspected. CPT2 gene analysis showed a homozygous complex haplotype for the F448L mutation associated with a c.del1238_1239AG (p.Q413fs) truncating mutation in exon 4. Carnitine palmitoyltransferase type II deficiency should be included in the differential diagnosis in fetuses of Ashkenazi origin with multicystic kidneys and unusual cerebral findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19335026     DOI: 10.2350/08-10-0548.1

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  9 in total

1.  Disorders of fatty acid oxidation and autosomal recessive polycystic kidney disease-different clinical entities and comparable perinatal renal abnormalities.

Authors:  Agnes Hackl; Katrin Mehler; Ingo Gottschalk; Anne Vierzig; Marcus Eydam; Jan Hauke; Bodo B Beck; Max C Liebau; Regina Ensenauer; Lutz T Weber; Sandra Habbig
Journal:  Pediatr Nephrol       Date:  2017-01-12       Impact factor: 3.714

Review 2.  Newborn screening and renal disease: where we have been; where we are now; where we are going.

Authors:  J Lawrence Merritt; David Askenazi; Si Houn Hahn
Journal:  Pediatr Nephrol       Date:  2011-09-27       Impact factor: 3.714

3.  PPARα agonist fenofibrate enhances fatty acid β-oxidation and attenuates polycystic kidney and liver disease in mice.

Authors:  Ronak Lakhia; Matanel Yheskel; Andrea Flaten; Ezekiel B Quittner-Strom; William L Holland; Vishal Patel
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-13

4.  Severe Hyperammonemic Encephalopathy Requiring Dialysis Aggravated by Prolonged Fasting and Intermittent High Fat Load in a Ramadan Fasting Month in a Patient with CPTII Homozygous Mutation.

Authors:  P Phowthongkum; C Ittiwut; V Shotelersuk
Journal:  JIMD Rep       Date:  2017-11-21

5.  Cerebral Lipid Accumulation Detected by MRS in a Child with Carnitine Palmitoyltransferase 2 Deficiency: A Case Report and Review of the Literature on Genetic Etiologies of Lipid Peaks on MRS.

Authors:  Carlos R Ferreira; Molly H Silber; Taeun Chang; Jonathan G Murnick; Brian Kirmse
Journal:  JIMD Rep       Date:  2015-11-05

6.  Advances in the Understanding and Treatment of Mitochondrial Fatty Acid Oxidation Disorders.

Authors:  Eric S Goetzman
Journal:  Curr Genet Med Rep       Date:  2017-07-25

7.  microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism.

Authors:  Sachin Hajarnis; Ronak Lakhia; Matanel Yheskel; Darren Williams; Mehran Sorourian; Xueqing Liu; Karam Aboudehen; Shanrong Zhang; Kara Kersjes; Ryan Galasso; Jian Li; Vivek Kaimal; Steven Lockton; Scott Davis; Andrea Flaten; Joshua A Johnson; William L Holland; Christine M Kusminski; Philipp E Scherer; Peter C Harris; Marie Trudel; Darren P Wallace; Peter Igarashi; Edmund C Lee; John R Androsavich; Vishal Patel
Journal:  Nat Commun       Date:  2017-02-16       Impact factor: 14.919

8.  Acute Respiratory Infection Unveiling CPT II Deficiency.

Authors:  Nicolas Blah; Bénédicte Sudrié-Arnaud; Stéphanie Torre; Stéphane Marret; Soumeya Bekri; Abdellah Tebani
Journal:  Int J Mol Sci       Date:  2018-09-27       Impact factor: 5.923

9.  Infantile onset carnitine palmitoyltransferase 2 deficiency: Cortical polymicrogyria, schizencephaly, and gray matter heterotopias in an adolescent with normal development.

Authors:  Ivan Shelihan; Elsa Rossignol; Jean-Claude Décarie; Jean-Paul Bonnefont; Michèle Brivet; Catherine Brunel-Guitton; Grant A Mitchell
Journal:  JIMD Rep       Date:  2021-09-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.